BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27556571)

  • 1. Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    Weis J; von Below C; Tolf A; Ortiz-Nieto F; Wassberg C; Häggman M; Ladjevardi S; Ahlström H
    J Magn Reson Imaging; 2017 Apr; 45(4):1232-1240. PubMed ID: 27556571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite ratios in 1H MR spectroscopic imaging of the prostate.
    Kobus T; Wright AJ; Weiland E; Heerschap A; Scheenen TW
    Magn Reson Med; 2015 Jan; 73(1):1-12. PubMed ID: 24488656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR spectroscopy of the prostate at 3T: measurements of relaxation times and quantification of prostate metabolites using water as an internal reference.
    Weis J; Ortiz-Nieto F; Ahlström H
    Magn Reson Med Sci; 2013 Dec; 12(4):289-96. PubMed ID: 24172792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.
    Basharat M; Payne GS; Morgan VA; Parker C; Dearnaley D; deSouza NM
    J Magn Reson Imaging; 2015 Oct; 42(4):1086-93. PubMed ID: 26258905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
    Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
    Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aging effect on prostate metabolite concentrations measured by
    Dezortova M; Jiru F; Skoch A; Capek V; Ryznarova Z; Vik V; Hajek M
    MAGMA; 2017 Feb; 30(1):65-74. PubMed ID: 27522359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
    Zakian KL; Eberhardt S; Hricak H; Shukla-Dave A; Kleinman S; Muruganandham M; Sircar K; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2003 Oct; 229(1):241-7. PubMed ID: 12920178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
    Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
    Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
    Ma C; Chen L; Scheenen TW; Lu J; Wang J
    Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate 3T-MR spectroscopic imaging without an endorectal surface coil using the MLEV-PRESS sequence.
    Yoshizako T; Uchida K; Hara S; Kaji Y; Sumura M; Igawa M; Kitagaki H; Uike M; Matsuda T
    Jpn J Radiol; 2013 Mar; 31(3):220-5. PubMed ID: 23207646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible proton 3D MR spectroscopic imaging of the prostate with low-power adiabatic pulses for volume selection and spiral readout.
    Steinseifer IK; Philips BW; Gagoski B; Weiland E; Scheenen TW; Heerschap A
    Magn Reson Med; 2017 Mar; 77(3):928-935. PubMed ID: 26968422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.